NCT02438735

Brief Summary

Prior studies have shown surgical excision of endometriomas are associated with a decline in ovarian reserve as assessed by serum anti-Mullerian Hormone (AMH) levels. However, the natural history of serum AMH levels in the presence of untreated endometriomas are unknown. Purpose of this study is to determine whether the presence of endometriomas cause a faster decline in serum AMH levels than in healthy women over a six months period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 6, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 8, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

December 19, 2017

Status Verified

December 1, 2017

Enrollment Period

2.3 years

First QC Date

May 6, 2015

Last Update Submit

December 16, 2017

Conditions

Keywords

ovarian endometriomasAMHovarian reserve

Outcome Measures

Primary Outcomes (1)

  • Change in Serum Anti- mullerian hormone (AMH) level

    at recruitment and six months later

Study Arms (3)

Endometrioma

Reproductive aged women diagnosed with endometrioma. Conservative follow up for six months.

Other: Conservative follow up

Healthy Controls

Women with regular menstrual cycles and without ovarian pathology will be recruited from physicians, nurses and other staff of the same hospital. Controls will be matched for age with the women in the endometrioma group. They will be conservatively followed up for six months.

Other: Conservative follow up

Historical controls who underwent surgical excision

20 women who underwent surgical excision of endometrioma in the same clinic had serum AMH levels measured preoperatively and on post operative sixth month. Their values will be compared with that of endometrioma group. These data were priorly published in detail (Uncu et al. 2013).

Procedure: laparoscopic endometrioma excision

Interventions

Historical controls who underwent surgical excision
EndometriomaHealthy Controls

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The decision to include a healthy control group was taken five months after starting recruitment of women with endometrioma. Only 12 women with endometriomas had been recruited until then and none of them had six month serum AMH level measured. Since healthy controls were reluctant to undergo transvaginal ultrasound examination, antral follicle counts were not measured as another marker of ovarian reserve for healthy controls and some women in the endometrioma group.

You may qualify if:

  • Reproductive age
  • Endometrioma without indication for surgery or treatment with combined contraceptive, progestin or other hormonal intervention.

You may not qualify if:

  • Menstrual cycle irregularity
  • Polycystic ovarian syndrome
  • Women who were pregnant or contemplating pregnancy in the next six months
  • History of ovarian surgery
  • Using medication which could affect ovarian function during six months before recruitment
  • Indication for surgical excision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uludag University Scholl of medicine

Bursa, Turkey/bursa, Turkey (Türkiye)

Location

Related Publications (2)

  • Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Oral Yilmaztepe A, Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013 Aug;28(8):2140-5. doi: 10.1093/humrep/det123. Epub 2013 Apr 26.

    PMID: 23624580BACKGROUND
  • Kasapoglu I, Ata B, Uyaniklar O, Seyhan A, Orhan A, Yildiz Oguz S, Uncu G. Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study. Fertil Steril. 2018 Jul 1;110(1):122-127. doi: 10.1016/j.fertnstert.2018.03.015. Epub 2018 Jun 20.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum Anti-mullerian hormone (AMH)

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • gürkan uncu

    Uludag University School of Medicine

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof.md

Study Record Dates

First Submitted

May 6, 2015

First Posted

May 8, 2015

Study Start

April 1, 2015

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

December 19, 2017

Record last verified: 2017-12

Locations